Recent research has identified a specific biological mechanism that may explain why females experience more severe ...

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

Partnership adds engineering and guidance to accelerate Bridge's AI development, and application of Ferguson's patented ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

CES 2026 shows a company that understands the direction of intelligent vehicles and is positioning itself directly in the ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve ...

Loosh launches a cognitive engine giving AI memory, ethics, and decentralized intelligence for real-world autonomy.

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Dr. Martin Teicher explains how immigrant trauma and family separation act as toxic stressors, permanently rewiring a child's ...